Published in Life Sci on July 09, 2004
A human genome diversity cell line panel. Science (2002) 14.11
Photoluminescence from chemically exfoliated MoS2. Nano Lett (2011) 3.42
The genome-wide structure of the Jewish people. Nature (2010) 3.37
Direct observation of local atomic order in a metallic glass. Nat Mater (2010) 2.39
The matrilineal ancestry of Ashkenazi Jewry: portrait of a recent founder event. Am J Hum Genet (2006) 2.18
Nanoporous metal/oxide hybrid electrodes for electrochemical supercapacitors. Nat Nanotechnol (2011) 1.94
Counting the founders: the matrilineal genetic ancestry of the Jewish Diaspora. PLoS One (2008) 1.92
Enhanced catalytic activity in strained chemically exfoliated WS₂ nanosheets for hydrogen evolution. Nat Mater (2013) 1.84
Five novel loci for inherited hearing loss mapped by SNP-based homozygosity profiles in Palestinian families. Eur J Hum Genet (2009) 1.67
Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. Ann Hum Genet (2009) 1.49
Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas. J Gastroenterol (2005) 1.47
Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease. Respirology (2012) 1.47
Systemic lupus erythematosus and blood type. Lancet (2006) 1.44
Clinicopathological study on hepatitis C virus-associated glomerulonephritis without hepatitis C virus in the blood. Intern Med (2010) 1.43
Conducting MoS₂ nanosheets as catalysts for hydrogen evolution reaction. Nano Lett (2013) 1.43
Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas. J Gastroenterol (2004) 1.43
Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn (2006) 1.43
MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population. Eur J Hum Genet (2004) 1.40
Coherent atomic and electronic heterostructures of single-layer MoS2. ACS Nano (2012) 1.35
From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community. Pharmacogenomics (2004) 1.31
The distribution and most recent common ancestor of the 17q21 inversion in humans. Am J Hum Genet (2010) 1.31
Tunable photoluminescence from graphene oxide. Angew Chem Int Ed Engl (2012) 1.27
The EU-ADR corpus: annotated drugs, diseases, targets, and their relationships. J Biomed Inform (2012) 1.23
Hypoxic conditions stimulate the production of angiogenin and vascular endothelial growth factor by human renal proximal tubular epithelial cells in culture. Nephrol Dial Transplant (2006) 1.13
Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem Biophys Res Commun (2002) 1.11
A global view of the OCA2-HERC2 region and pigmentation. Hum Genet (2011) 1.08
Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis. Clin Exp Nephrol (2006) 1.06
Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe. Pharmacogenomics (2006) 1.06
Personalized medicine: decades away? Pharmacogenomics (2006) 1.04
Single nucleotide polymorphism of the human high affinity choline transporter alters transport rate. J Biol Chem (2002) 1.03
Adenoma, adenocarcinoma and mixed carcinoid-adenocarcinoma arising in a small lesion of the colon. Pathol Int (2003) 1.02
QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals. J Pharmacol Sci (2005) 1.00
Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker. Pharmacogenomics (2011) 0.99
Cirrhosis or chronic hepatitis: evaluation of small (<or=2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology (2003) 0.97
Serrated adenoma of the colorectum undergoes a proliferation versus differentiation process: new conceptual interpretation of morphogenesis. Oncology (2008) 0.97
Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF). Curr Eye Res (2006) 0.96
A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy. BMC Nephrol (2013) 0.95
Analysis of Ki-ras and p53 gene mutations in laterally spreading tumors of the colorectum. Pathol Int (2003) 0.95
Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2). J Pharmacol Exp Ther (2008) 0.94
Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients. Pharmacogenomics (2007) 0.94
Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics (2007) 0.93
Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers. Pharmacogenomics (2012) 0.93
Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers--a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod Pathol (2004) 0.92
Overexpression of MDM2 in a sclerosing epithelioid fibrosarcoma: genetic, immunohistochemical and ultrastructural study of a case. Pathol Int (2002) 0.92
Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs. J Affect Disord (2011) 0.91
Sterol regulatory element binding proteins: relationship of adipose tissue gene expression with obesity in humans. Biochim Biophys Acta (2002) 0.91
Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas. J Pathol (2003) 0.91
Use of anonymous Web communities and websites by medical consumers in Japan to research drug information. Yakugaku Zasshi (2011) 0.91
Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing. Pharmacogenomics (2007) 0.89
Human lymphoblastoid cell line panels: novel tools for assessing shared drug pathways. Pharmacogenomics (2010) 0.88
Pharmacogenetics education in British medical schools. Genomic Med (2009) 0.88
Li storage in 3D nanoporous Au-supported nanocrystalline tin. Adv Mater (2011) 0.88
Hepatic enhancement in multiphasic contrast-enhanced MDCT: comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease. AJR Am J Roentgenol (2004) 0.88
Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions. AJR Am J Roentgenol (2004) 0.88
Molecular validation of the modified Vienna classification of colorectal tumors. J Mol Diagn (2002) 0.88
QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation. J Pharmacol Sci (2005) 0.87
Self-grown oxy-hydroxide@ nanoporous metal electrode for high-performance supercapacitors. Adv Mater (2013) 0.87
Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts. Int J Cancer (2014) 0.86
Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin. Chem Commun (Camb) (2009) 0.86
Genome-wide association studies: powerful tools for improving drug safety and efficacy. Pharmacogenomics (2009) 0.86
High catalytic activity of nitrogen and sulfur co-doped nanoporous graphene in the hydrogen evolution reaction. Angew Chem Int Ed Engl (2014) 0.86
'Drug reactions, enzymes, and biochemical genetics': 50 years later. Pharmacogenomics (2007) 0.85
Health technology assessment in the era of personalized health care. Int J Technol Assess Health Care (2011) 0.85
TPU-0037-A, B, C and D, novel lydicamycin congeners with anti-MRSA activity from Streptomyces platensis TP-A0598. J Antibiot (Tokyo) (2002) 0.84
Highly multiplexed genotyping of coronary artery disease-associated SNPs using MALDI-TOF mass spectrometry. Hum Mutat (2002) 0.84
Serum and tissue metabolomics of head and neck cancer. Cancer Genomics Proteomics (2013) 0.84
Human intestinal spirochaetosis in northern Japan. J Med Microbiol (2010) 0.84
Ethnic differences in CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) genotypes in Japanese and Israeli populations. Life Sci (2005) 0.83
Cobalt-catalyzed hydroarylation of alkynes through chelation-assisted C-H bond activation. J Am Chem Soc (2010) 0.83
Increased thrombin inhibition in experimental autoimmune encephalomyelitis. J Neurosci Res (2005) 0.83
Large enhancement of quantum dot fluorescence by highly scalable nanoporous gold. Adv Mater (2013) 0.83
Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging. Magn Reson Imaging (2007) 0.83
An adult case of nephrotic syndrome presenting with pulmonary artery thrombosis: a case report. J Med Case Rep (2013) 0.82
[Pathological Diagnosis and Its Molecular Basis in Colorectal Cancer]. Gan To Kagaku Ryoho (2016) 0.82
A genetic association between ß3-aderenoceptor and cholinergic receptor muscarinic 3 polymorphisms in irritable bowel syndrome. Hepatogastroenterology (2011) 0.82
Cobalt-catalyzed, room-temperature addition of aromatic imines to alkynes via directed C-H bond activation. J Am Chem Soc (2011) 0.82
Molecular analysis of gastric differentiated-type intramucosal and submucosal cancers. Int J Cancer (2010) 0.82
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients. J Mol Neurosci (2015) 0.81
Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers. Oncology (2005) 0.81
Beneficial effect of neutrophil elastase inhibitor on anti-Thy1.1 nephritis in rats. Nephrology (Carlton) (2008) 0.81
Extracellular matrix metalloproteinase inducer is expressed in the proximal tubular epithelial cells of the human kidney. Nephrology (Carlton) (2009) 0.81
Correlation between diffusion in lumbar intervertebral disks and lumbar artery status: evaluation with fresh blood imaging technique. J Magn Reson Imaging (2007) 0.81
Induction of CYP1 family members under low-glucose conditions requires AhR expression and occurs through the nuclear translocation of AhR. Drug Metab Pharmacokinet (2011) 0.81
Synthesis and optical properties of three-dimensional porous core-shell nanoarchitectures. Langmuir (2008) 0.81
Allelotype analysis of the PTEN, Smad4 and DCC genes in biliary tract cancer. Anticancer Res (2002) 0.81
Analysis of allelic imbalances at multiple cancer-related chromosomal loci and microsatellite instability within the same tumor using a single tumor gland from colorectal carcinomas. Int J Cancer (2005) 0.81
Coronary vasospasm induced in transgenic mouse with increased phospholipase C-δ1 activity. Circulation (2012) 0.81
Usefulness of three-dimensional angiographic analysis of perigastric vessels before laparoscopic gastrectomy. Gastric Cancer (2012) 0.81
Identification of six novel P450 oxidoreductase missense variants in Ashkenazi and Moroccan Jewish populations. Pharmacogenomics (2012) 0.81
Roxithromycin inhibits transforming growth factor-beta production by cultured human mesangial cells. Nephrology (Carlton) (2006) 0.81